…
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Oscar Health is a technology-oriented health insurer offering individual, small-group and Medicare Advantage plans alongside a digital care-navigation and claims platform. Long-term growth drivers include expansion in Medicare Advantage and employer channels, scaling its tech-enabled distribution and care-management capabilities, and potential underwriting improvements as membership mix evolves. Investors may find it attractive because the company appears positioned to leverage data and a consumer-focused platform to improve engagement and unit economics.
Key investment risks include persistent underwriting losses and medical-cost inflation, intense competition from large national insurers, regulatory and reimbursement changes, and potential capital or execution challenges.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -437.30M | 33.43M | -267.30M | -610.08M | -570.58M |
| Minority interest | -0.25M | -0.69M | 0.57M | 3.28M | -1.18M |
| Net income | -443.15M | 25.43M | -270.73M | -609.55M | -571.43M |
| Selling general administrative | 2049.87M | 1755.94M | 339.72M | 309.78M | 265.08M |
| Selling and marketing expenses | - | - | 65.75M | - | - |
| Gross profit | 1682.40M | 1844.97M | 5862.87M | 4125.58M | 1920.96M |
| Reconciled depreciation | 28.89M | 32.15M | 26.69M | 15.28M | 14.61M |
| Ebit | -419.94M | 57.16M | -235.62M | -584.17M | -577.06M |
| Ebitda | -391.05M | 89.31M | -235.62M | -568.89M | -562.46M |
| Depreciation and amortization | 28.89M | 32.15M | 30.69M | 15.28M | 14.61M |
| Non operating income net other | - | - | - | - | -21.38M |
| Operating income | -396.36M | 57.27M | -235.62M | -584.17M | -577.06M |
| Other operating expenses | 12097.78M | 9120.30M | 6098.48M | 4735.66M | 2491.54M |
| Interest expense | 17.60M | 23.73M | 24.60M | 22.62M | 4.72M |
| Tax provision | 5.61M | 7.30M | 3.38M | -0.52M | 0.85M |
| Interest income | - | - | - | 31.31M | 10.25M |
| Net interest income | -17.60M | -23.73M | -24.52M | -22.62M | -4.72M |
| Income tax expense | 5.61M | 7.30M | 3.29M | -0.52M | 0.85M |
| Total revenue | 11701.43M | 9177.56M | 5862.87M | 4125.58M | 1920.96M |
| Total operating expenses | 2078.76M | 1787.71M | 6098.48M | 4553.51M | -2498.02M |
| Cost of revenue | 10019.02M | 7332.59M | 4643.03M | - | - |
| Total other income expense net | -40.94M | -23.84M | -31.68M | -25.90M | 6.48M |
| Net income from continuing ops | -442.90M | 26.12M | -347.32M | -609.55M | -571.43M |
| Net income applicable to common shares | - | - | - | -606.27M | -572.61M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 6325.41M | 4840.50M | 3601.48M | 4526.60M | 3321.65M |
| Other current assets | 180.15M | 377.64M | 299.68M | 1165.67M | 614.85M |
| Total liab | 5344.68M | 3824.07M | 2795.36M | 3634.20M | 440.02M |
| Total stockholder equity | 977.65M | 1013.59M | 803.97M | 890.38M | 1387.23M |
| Other current liab | 4962.34M | 1773.62M | 2094.62M | 2538.43M | -440.02M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -3294.43M | -2851.28M | -2876.72M | -2605.99M | -1999.71M |
| Other liab | - | - | - | 0.10M | 76.84M |
| Other assets | - | - | 241.19M | 4526.60M | 817.80M |
| Cash | 2774.15M | 1527.19M | 1870.32M | 1558.60M | 1103.99M |
| Total current liabilities | 4862.59M | 3171.70M | 2429.01M | 3263.92M | 440.02M |
| Net debt | -2344.06M | -1227.63M | -1571.54M | -1260.60M | -1103.99M |
| Short long term debt total | 430.10M | 299.56M | 298.78M | 298.00M | 297.42M |
| Other stockholder equity | 4254.05M | 3866.69M | 3679.37M | 3506.08M | 68.96M |
| Property plant equipment | - | - | - | 59.89M | 46.61M |
| Total current assets | 4613.40M | 2845.17M | 2819.91M | 4121.56M | 1870.15M |
| Long term investments | 1216.46M | 624.46M | 689.83M | 1397.29M | 587.09M |
| Net tangible assets | - | - | - | 890.38M | 1387.23M |
| Short term investments | 1216.46M | 624.46M | 689.83M | 1397.29M | 587.09M |
| Net receivables | 442.64M | 315.89M | 201.27M | 1159.22M | 179.07M |
| Long term debt | 430.10M | 299.56M | 298.78M | 298.00M | - |
| Inventory | - | - | -3054.54M | -1159.22M | -614.85M |
| Accounts payable | -99.75M | 1398.08M | 334.39M | 725.49M | 440.02M |
| Noncontrolling interest in consolidated entity | - | - | - | 2.02M | 5.29M |
| Accumulated other comprehensive income | 18.03M | -1.83M | 1.31M | -9.71M | -3.67M |
| Common stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | -2605.99M | -1999.71M |
| Treasury stock | - | - | - | -2.92M | -2.92M |
| Non currrent assets other | 152.67M | 113.28M | 113.14M | -1052.13M | -633.70M |
| Non current assets total | 1712.01M | 1995.32M | 540.38M | 405.05M | 633.70M |
| Long term debt total | - | - | - | 298.00M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -208.96M | -1387.43M | -301.97M | -226.52M | -755.30M |
| Change to liabilities | - | - | - | 259.15M | 101.76M |
| Total cashflows from investing activities | -241.06M | -1387.43M | 577.19M | -226.52M | -774.51M |
| Net borrowings | 410.00M | 0.00M | 0.00M | 297.96M | -153.17M |
| Total cash from financing activities | 399.21M | 68.39M | 6.45M | 301.11M | 1238.71M |
| Change to operating activities | - | - | - | 874.28M | 212.89M |
| Net income | -442.90M | 26.12M | -270.59M | -609.55M | -571.43M |
| Change in cash | 1253.01M | -340.85M | 311.47M | 454.94M | 282.45M |
| Begin period cash flow | 1551.12M | 1891.97M | 1580.50M | 1125.56M | 843.11M |
| End period cash flow | 2804.12M | 1551.12M | 1891.97M | 1580.50M | 1125.56M |
| Total cash from operating activities | 1094.85M | 978.19M | -272.16M | 380.35M | -181.75M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 1348.32M |
| Depreciation | 28.89M | 32.15M | 30.69M | 15.28M | 14.61M |
| Other cashflows from investing activities | 4.28M | 3.93M | -2.28M | 1.12M | 6.67M |
| Change to inventory | - | - | -477.15M | - | - |
| Change to account receivables | 98.57M | -177.52M | 636.23M | -538.96M | 80.45M |
| Sale purchase of stock | - | - | - | 3.15M | 1404.88M |
| Other cashflows from financing activities | -4.04M | 68.39M | 2.49M | 299.81M | 43.56M |
| Change to netincome | - | - | - | 113.44M | 128.23M |
| Capital expenditures | 36.37M | 27.90M | 25.58M | 29.01M | 25.89M |
| Change receivables | - | - | - | -538.96M | 78.53M |
| Cash flows other operating | - | - | - | 1137.80M | 260.81M |
| Cash and cash equivalents changes | - | - | - | 454.94M | 282.45M |
| Change in working capital | 1459.00M | 838.86M | -192.09M | 857.99M | 247.70M |
| Stock based compensation | 87.65M | 109.82M | 159.68M | 112.33M | 86.30M |
| Other non cash items | -40.24M | -26.42M | 0.09M | 4.47M | 41.19M |
| Free cash flow | 1058.48M | 950.30M | -297.74M | 351.34M | -207.63M |
Sector: Healthcare Industry: Healthcare Plans
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health Inc |
1.05 3.44% |
31.70 | 25.95 | 588.24 | 0.65 | 5.08 | 0.44 |
| UNH UnitedHealth Group Incorporated |
4.39 1.11% |
398.54 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 |
| CVS CVS Health Corp |
1.70 2.03% |
85.55 | 55.65 | 10.80 | 0.25 | 1.32 | 0.42 |
| ELV Elevance Health Inc |
-1.89 0.44% |
423.73 | 18.47 | 14.58 | 0.45 | 2.05 | 0.56 |
| CI The Cigna Group |
3.67 1.25% |
297.25 | 11.94 | 8.68 | 0.27 | 1.80 | 0.36 |
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
| Name | Title | Year Born |
|---|---|---|
| Mr. Mario Tobias Schlosser | Co-Founder, CEO & Director | 1979 |
| Mr. Joshua Kushner | Co-Founder & Vice Chairman | 1985 |
| Mr. Siddhartha Sankaran | Interim CFO & Director | 1978 |
| Mr. Richard Scott Blackley CPA, CPA | Chief Transformation Officer | 1968 |
| Ms. Alessandrea Corinne Quane | Exec. VP & Chief Insurance Officer | 1970 |
| Ms. Victoria Baltrus | Chief Accounting Officer | 1970 |
| Cornelia Miller | VP of Investor Relations | NA |
| Ms. Ranmali Bopitiya | Chief Legal Officer | NA |
| Mr. Joel I. Klein | Sr. Advisor | 1947 |
| Dr. Dennis Weaver M.D. | Chief Clinical Officer | 1961 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.